Previous chapter   | Back to the title page | E-thesis main page


Aase, K., et al. (1999). Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature. Dev Dyn 215(1): 12-25.

Aase, K., et al. (2001). Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect. Circulation 104(3): 358-364.

Abedi, H. and I. Zachary (1997). Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 272(24): 15442-15451.

Aboul-Enein, A., et al. (1984). The role of lymphovenous communication in the development of postmastectomy lymphedema. Surgery 95(5): 562-566.

Achen, M. G., et al. (2000). Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3. Eur J Biochem 267(9): 2505-2515.

Asahara, T., et al. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85(3): 221-228.

Asahara, T., et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302): 964-967.

Ausprunk, D. H., et al. (1974). Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev Biol 38(2): 237-248.

Avantaggiato, V., et al. (1998). Embryonic expression pattern of the murine figf gene, a growth factor belonging to platelet-derived growth factor/vascular endothelial growth factor family. Mech Dev 73(2): 221-224.

Baldwin, M. E., et al. (2001a). The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. J Biol Chem 276(22): 19166-19171.

Baldwin, M. E., et al. (2001b). Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis. J Biol Chem 276(47): 44307-44314.

Barleon, B., et al. (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87(8): 3336-3343.

Barleon, B., et al. (1997). Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J Biol Chem 272(16): 10382-10388.

Bates, D. O., et al. (1994). Starling pressures in the human arm and their alteration in postmastectomy oedema. J Physiol-London 477 ( Pt 2): 355-363.

Bautch, V. L., et al. (2000). Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A. Blood 95(6): 1979-1987.

Bergstrom, K. and B. Werner (1966). Proteins in human thoracic duct lymph. Studies on the distribution of some proteins between lymph and blood. Acta Chir Scand 131(5): 413-422.

Betsholtz, C. et al. (2001). Developmental roles of platelet-derived growth factors. Bioessays 23(6): 494-507.

Bierman, H. R., et al. (1953). The characteristics of thoracic duct lymph in man. J Clin Invest 32: 637-649.

Birner, P., et al. (2001). Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer 95(1): 29-33.

Blagosklonny, M. V. (2001). Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy (review). Int J Oncol 19(2): 257-262.

Blechman, J. M., et al. (1995). The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell 80(1): 103-113.

Bollinger, A., et al. (1983). Aplasia of superficial lymphatic capillaries in hereditary and connatal lymphedema (Milroy's disease). Lymphology 16(1): 27-30.

Borg, J. P., et al. (1995). Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase. Oncogene 10(5): 973-984.

Butler, H. and B. Juurlink (1987). An atlas for staging mammalian and chick embryos. Boca Raton, Florida, CRC Press Inc.

Byzova, T. V., et al. (2002). Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood 99(12): 4434-4442.

Cao, Y. (2001). Endogenous angiogenesis inhibitors and their therapeutic implications. Int J Biochem Cell Biol 33(4): 357-369.

Cao, Y., et al. (1998). Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 95(24): 14389-14394.

Carmeliet, P. (2000a). Mechanisms of angiogenesis and arteriogenesis. Nat Med 6(4): 389-395.

Carmeliet, P. (2000b). VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med 6(10): 1102-1103.

Carmeliet, P., et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380(6573): 435-439.

Carmeliet, P. and R. K. Jain (2000). Angiogenesis in cancer and other diseases. Nature 407(6801): 249-257.

Carmeliet, P., et al. (1999a). Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98(2): 147-157.

Carmeliet, P., et al. (2001). Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7(5): 575-583.

Carmeliet, P., et al. (1999b). Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 5(5): 495-502.

Carter, C. L., et al. (1989). Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63(1): 181-187.

Casley-Smith, J. R. (1980). The fine structure and functioning of tissue channels and lymphatics. Lymphology 13(4): 177-183.

Casley-Smith, J. R. (1982a). Mechanisms in the formation of lymph. International Review of Physiology. Cardiovascular Physiology IV. A. C. Guyton and J. E. Hall. Baltimore (MD), University Park. 26: 147-187.

Casley-Smith, J. R. (1982b). "Prelymphatic": a question of terminology? Experientia 38(9): 1123-1124.

Casley-Smith, J. R., et al. (1976). The prelymphatic pathways of the brain as revealed by cervical lymphatic obstruction and the passage of particles. Br J Exp Pathol 57(2): 179-188.

Celis, A. V., et al. (1999). Acquired lymphangiectasis. South Med J 92(1): 69-72.

Chang, C. C., et al. (1999). Evolution of a cytokine using DNA family shuffling. Nat Biotechnol 17(8): 793-797.

Cheng, N., et al. (2002). The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 13(1): 75-85.

Chilov, D., et al. (1997). Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem 272(40): 25176-25183.

Cho, N. K., et al. (2002). Developmental control of blood cell migration by the Drosophila VEGF pathway. Cell 108(6): 865-876.

Ciau-Uitz, A., et al. (2000). Distinct origins of adult and embryonic blood in Xenopus. Cell 102(6): 787-796.

Claesson-Welsh, L., et al. (1988). cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cell Biol 8: 3476-3486.

Claesson-Welsh, L., et al. (1989). cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc Natl Acad Sci USA 86(13): 4917-4921.

Clark, A. H. (1912). On the fate of the Jugular Lymph Sacs and the Development of the Lymph channels in the neck of the pig. Am J Anat 14: 47-62.

Clark, E. R. and E. L. Clark (1920). On the origin and early development of the lymphatic system of the chick. Contr Embryol 9: 447-482.

Clark, E. R. and E. L. Clark (1932). Observations on the New Growth of Lymphatic vessels as seen in transparent chambers introduced into the rabbit's ear. Am J Anat 51(1): 49-87.

Clauss, M., et al. (1990). Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172(6): 1535-1545.

Crosby, J. R., et al. (2000). Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 87(9): 728-730.

Cunningham, S. A., et al. (1997a). Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites. Biochem Biophys Res Commun 240(3): 635-639.

Cunningham, S. A., et al. (1997b). Identification of the extracellular domains of Flt-1 that mediate ligand interactions. Biochem Biophys Res Commun 231(3): 596-599.

Davis-Smyth, T., et al. (1996). The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J 15(18): 4919-4927.

de Bruijn, M. F., et al. (2000). Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J 19(11): 2465-2474.

Deegan, R. D. (2000). Pattern formation in drying drops. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 61(1): 475-485.

Detmar, M., et al. (1998). Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111(1): 1-6.

Dimmeler, S., et al. (1999). Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399(6736): 601-605.

Dougher, A. M., et al. (1997). Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor. Growth Factors 14(4): 257-268.

Dreyer, G., et al. (2000). Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today 16(12): 544-548.

Duchek, P., et al. (2001). Guidance of cell migration by the Drosophila PDGF/VEGF receptor. Cell 107(1): 17-26.

Dumont, D. J., et al. (1998). Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282(5390): 946-949.

Dunk, C. and A. Ahmed (2001). Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast. Histol Histopathol 16(2): 359-375.

Dvorak, H. F., et al. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146(5): 1029-1039.

Eichmann, A., et al. (1998). Avian VEGF-C: cloning, embryonic expression pattern and stimulation of the differentiation of VEGFR2-expressing endothelial cell precursors. Development 125(4): 743-752.

Eichmann, A., et al. (1997). Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc Natl Acad Sci USA 94(10): 5141-5146.

Eichmann, A., et al. (1993). Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development. Mech Dev 42(1-2): 33-48.

Elson, D. A., et al. (2001). Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev 15(19): 2520-2532.

Enholm, B., et al. (1997). Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14(20): 2475-2483.

Esiri, M. M. and D. Gay (1990). Immunological and neuropathological significance of the Virchow-Robin space. J Neurol Sci 100(1-2): 3-8.

Fairbrother, W. J., et al. (1998). Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure 6(5): 637-648.

Fang, J., et al. (2000). Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 67(6): 1382-1388.

Farnebo, F., et al. (1999). Restricted expression pattern of vegf-d in the adult and fetal mouse: high expression in the embryonic lung. Biochem Biophys Res Commun 257(3): 891-894.

Ferrara, N. (2001). Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280(6): C1358-1366.

Ferrara, N., et al. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380(6573): 439-442.

Ferrell, R. E., et al. (1998). Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum Mol Genet 7(13): 2073-2078.

Finegold, D. N., et al. (2001). Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet 10(11): 1185-1189.

Fisher, B., et al. (1969). Cancer of the breast: size of neoplasm and prognosis. Cancer 24(5): 1071-1080.

Fitz, L. J., et al. (1997). Characterization of murine Flt4 ligand/VEGF-C. Oncogene 15(5): 613-618.

Foets, B., et al. (1992). A comparative immunohistochemical study of human corneotrabecular tissue. Graef Arch Clin Exp 230(3): 269-274.

Folberg, R., et al. (2000). Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156(2): 361-381.

Fong, G. H., et al. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376(6535): 66-70.

Fong, G. H., et al. (1999). Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126(13): 3015-3025.

Foster, R. S., Jr. (1996). General anatomy of the lymphatic system. Surg Oncol Clin N Am 5(1): 1-13.

Fournier, E., et al. (1995). Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor. Oncogene 11(5): 921-931.

Fournier, E., et al. (1996). Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase. J Biol Chem 271(22): 12956-12963.

Fuh, G., et al. (1998). Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J Biol Chem 273(18): 11197-11204.

Fulton, D., et al. (1999). Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399(6736): 597-601.

Gabrilovich, D. I., et al. (1996). Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2(10): 1096-1103.

Galland, F., et al. (1993). The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 8(5): 1233-1240.

Gasmi, A., et al. (2000). Purification and characterization of a growth factor-like which increases capillary permeability from Vipera lebetina venom. Biochem Biophys Res Commun 268(1): 69-72.

Gasmi, A., et al. (2002). Complete structure of an increasing capillary permeability protein (ICPP) purified from Vipera lebetina venom. ICPP is angiogenic via vascular endothelial growth factor receptor signalling. J Biol Chem 277(33): 29992-29998.

Gengrinovitch, S., et al. (1999). Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J Biol Chem 274(16): 10816-10822.

Gerber, H. P., et al. (1998a). Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273(21): 13313-13316.

Gerber, H. P., et al. (1998b). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273(46): 30336-30343.

Gerber, H. P., et al. (1999). VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5(6): 623-628.

Gilewski, M. K., et al. (1996). Congenital pulmonary lymphangiectasia and other anomalies in a child: provisionally unique syndrome? Am J Med Genet 66(4): 438-440.

Gitay-Goren, H., et al. (1992). The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 267(9): 6093-6098.

Gluzman-Poltorak, Z., et al. (2000). Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]. J Biol Chem 275(24): 18040-18045.

Hammond, H. K. and M. D. McKirnan (2001). Angiogenic gene therapy for heart disease: a review of animal studies and clinical trials. Cardiovasc Res 49(3): 561-567.

Hanahan, D. and J. Folkman (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.

Harpaz, Y. and C. Chothia (1994). Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. J Mol Biol 238(4): 528-539.

Heino, T. I., et al. (2001). The Drosophila VEGF receptor homolog is expressed in hemocytes. Mech Dev 109(1): 69-77.

Heiring, C. and Y. A. Muller (2001). Folding screening assayed by proteolysis: application to various cystine deletion mutants of vascular endothelial growth factor. Protein Eng 14(3): 183-188.

Hennekam, R. C., et al. (1989). Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am J Med Genet 34(4): 593-600.

Hiltunen, M. O., et al. (2000). Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 102(18): 2262-2268.

Hiratsuka, S., et al. (1998). Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 95(16): 9349-9354.

Hogan, R. D. and J. L. Unthank (1986). Mechanical control of initial lymphatic contractile behavior in bat's wing. Am J Physiol 251(2 Pt 2): H357-363.

Holberg, C. J., et al. (2001). Segregation analyses and a genome-wide linkage search confirm genetic heterogeneity and suggest oligogenic inheritance in some Milroy congenital primary lymphedema families. Am J Med Genet 98(4): 303-312.

Houck, K. A., et al. (1991). The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5(12): 1806-1814.

Hoyer, H. (1934). Das Lymphgefäßsystem der Wirbeltiere vom Standpunkte der vergleichenden Anatomie. Mem Acad Polon Sci Lett Med 1(1): 1-205.

Hu, J. S., et al. (1997). A novel regulatory function of proteolytically cleaved VEGF-2 for vascular endothelial and smooth muscle cells. FASEB J 11(6): 498-504.

Hughes, D. C. (2001). Alternative splicing of the human VEGFGR-3/FLT4 gene as a consequence of an integrated human endogenous retrovirus. J Mol Evol 53(2): 77-79.

Huntington, G. S. and C. F. W. McClure (1910). The anatomy and development of the jugular lymph sac in the domestic cat (Felis domestica). Am J Anat 10: 177-311.

Isner, J. M., et al. (1996). Clinical evidence of angiogenesis following arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348: 370-374.

Iyer, S., et al. (2001). The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution. J Biol Chem 276(15): 12153-12161.

Jackson, D. G., et al. (2001). LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 22(6): 317-321.

Jain, R. K. and L. E. Gerlowski (1986). Extravascular transport in normal and tumor tissues. Crit Rev Oncol Hemat 5(2): 115-170.

Janse, A. J., et al. (1995). Lymphedema-induced lymphangiosarcoma. Eur J Surg Oncol 21(2): 155-158.

Jiang, B. H., et al. (2000). Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci USA 97(4): 1749-1753.

Job, T. T. (1918). Lymphatico-venous communications in the common rat and their significance. Am J Anat 24: 467-491.

Jones, N., et al. (2001). Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2(4): 257-267.

Joukov, V., et al. (1998). A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem 273(12): 6599-6602.

Joukov, V., et al. (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases [published erratum appears in EMBO J 1996 Apr 1;15(7):1751]. EMBO J 15(2): 290-298.

Joukov, V., et al. (1997). Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16(13): 3898-3911.

Junqueira de Azevedo, I. L., et al. (2001). Molecular cloning and expression of a functional snake venom vascular endothelium growth factor (VEGF) from the Bothrops insularis pit viper. A new member of the VEGF family of proteins. J Biol Chem 276(43): 39836-39842.

Kääriäinen, H. (1984). Hereditary lymphedema: a new combination of symptoms not fitting into present classifications. Clin Genet 26: 254-256.

Kaipainen, A., et al. (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92(8): 3566-3570.

Kampmeier, O. F. (1912). The development of the thoracic duct in the pig. Am J Anat 13: 401-475.

Karkkainen, M. J., et al. (2000). Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25(2): 153-159.

Karkkainen, M. J., et al. (2001). A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 98(22): 12677-12682.

Karpanen, T., et al. (2001). Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61(5): 1786-1790.

Keck, P. J., et al. (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246(4935): 1309-1312.

Keck, R. G., et al. (1997). Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF. Arch Biochem Biophys 344(1): 103-113.

Kenney, W. C., et al. (1994). Formation of mitogenically active PDGF-B dimer does not require interchain disulfide bonds. J Biol Chem 269(16): 12351-12359.

Keyt, B. A., et al. (1996a). The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271(13): 7788-7795.

Keyt, B. A., et al. (1996b). Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 271(10): 5638-5646.

Kinmonth, J. and G. Taylor (1956). Spontaneous rhythmic contractility in human lymphatics. J Physiol-London 133: 3P.

Kinnaert, P. (1973). Pressure measurements in the cervical portion of the thoracic duct in man. Br J Surg 60(7): 558-561.

Klein, J. (1990). Immunology. Oxford, Blackwell Scientific Publications Inc.

Komori, Y., et al. (1999). Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis aspis (Aspic viper). Biochemistry 38(36): 11796-11803.

Korpelainen, E. I., et al. (1999). Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene 18(1): 1-8.

Kotani, M. (1990).

New Concepts related to the Evolution of Lymphatics. Progress in Lymphology - XIIth (International Congress Series No. 887), Elsevier Science Publishers B.V.

Kroll, J. and J. Waltenberger (1997). The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 272(51): 32521-32527.

Kukk, E., et al. (1996). VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122(12): 3829-3837.

Lagercrantz, J., et al. (1998). A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse. Biochim Biophys Acta 1398(2): 157-163.

Laitinen, M., et al. (1997). Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Endocrinology 138(11): 4748-4756.

Lammert, E., et al. (2001). Induction of pancreatic differentiation by signals from blood vessels. Science 294(5542): 564-567.

Landis, E. M. and J. R. Pappenheimer (1963). Exchange of substances through the capillary wall. Handbook of Physiology. Washington, American Physiological Society. 2.2.

Laurent, P., et al. (1978). The Vasculature of the Gills in the Aquatic and Aestivating Lungfish (Protopterus aethiopicus). J Morphol 156: 173-208.

Leak, L. V. (1970). Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvasc Res 2(4): 361-391.

Leak, L. V. (1971). Studies on the permeability of lymphatic capillaries. J Cell Biol 50(2): 300-323.

Lee, J., et al. (1996). Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 93(5): 1988-1992.

Lei, J., et al. (1998). Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183. Biochim Biophys Acta 1443(3): 400-406.

Lemmon, M. A., et al. (1997). Kit receptor dimerization is driven by bivalent binding of stem cell factor. J Biol Chem 272(10): 6311-6317.

Leu, A. J., et al. (2000). Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60(16): 4324-4327.

Leung, D. W., et al. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246(4935): 1306-1309.

Li, X., et al. (2001). Isoform-specific expression of VEGF-B in normal tissues and tumors. Growth Factors 19(1): 49-59.

Linder, E. and R. Blomstrand (1958). Technic for Collection of Thoracic Duct Lymph of Man. Proc Soc Exp Biol Med 97: 653-657.

Luttun, A., et al. (2002). Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8(8): 831-840.

Lymboussaki, A., et al. (1999). Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia. Circ Res 85(11): 992-999.

Lyttle, D. J., et al. (1994). Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J Virol 68(1): 84-92.

Maglione, D., et al. (2000). Recombinant production of PIGF-1 and its activity in animal models. Farmaco 55(3): 165-167.

Maglione, D., et al. (1993). Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 8(4): 925-931.

Mahadevan, D., et al. (1995). Structural role of extracellular domain 1 of alpha-platelet-derived growth factor (PDGF) receptor for PDGF-AA and PDGF-BB binding. J Biol Chem 270(46): 27595-27600.

Makinen, T., et al. (2001a). Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7(2): 199-205.

Makinen, T., et al. (1999). Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J Biol Chem 274(30): 21217-21222.

Makinen, T., et al. (2001b). Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20(17): 4762-4773.

Mandriota, S. J., et al. (2001). Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20(4): 672-682.

Maniotis, A. J., et al. (1999). Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155(3): 739-752.

Marconcini, L., et al. (1999). c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci USA 96(17): 9671-9676.

Masaki, I., et al. (2002). Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res 90(9): 966-973.

Matsumoto, K., et al. (2001). Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294(5542): 559-563.

Mayer, P. (1919). Über die Lymphgefäße der Fische und ihre mutmaßliche Rolle bei der Verdauung. Jena Z Naturwiss 55: 125-174.

McDonald, D. M., et al. (2000). Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol 156(2): 383-388.

McDonald, N. Q. and W. A. Hendrickson (1993). A structural superfamily of growth factors containing a cystine knot motif. Cell 73(3): 421-424.

McDonald, N. Q., et al. (1991). New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. Nature 354(6352): 411-414.

Meyer, M., et al. (1999). A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J 18(2): 363-374.

Midy, V. and J. Plouet (1994). Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 199(1): 380-386.

Migdal, M., et al. (1998). Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem 273(35): 22272-22278.

Mimura, T., et al. (2001). Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis. Exp Eye Res 72(1): 71-78.

Miquerol, L., et al. (1999). Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. Dev Biol 212(2): 307-322.

Muller, Y. A., et al. (1997a). The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding. Structure 5(10): 1325-1338.

Muller, Y. A., et al. (1997b). Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc Natl Acad Sci USA 94(14): 7192-7197.

Neufeld, G., et al. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13(1): 9-22.

Neufeld, G., et al. (2002). The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 12(1): 13-19.

Niiro, G. K. and C. C. O'Morchoe (1986). Pattern and distribution of intrahepatic lymph vessels in the rat. Anat Rec 215(4): 351-360.

Oefner, C., et al. (1992). Crystal structure of human platelet-derived growth factor BB. EMBO J 11(11): 3921-3926.

Ogawa, S., et al. (1998). A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J Biol Chem 273(47): 31273-31282.

Ohtani, O., et al. (1998). Lymphatics of the rat mammary gland during virgin, pregnant, lactating and post-weaning periods. Ital J Anat Embryol 103(4 Suppl 1): 335-342.

Oliver, G. and M. Detmar (2002). The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 16(7): 773-783.

Olofsson, B., et al. (1998). Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 95(20): 11709-11714.

Olofsson, B., et al. (1996). Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem 271(32): 19310-19317.

Olszewski, W. L. and A. Engeset (1980). Intrinsic contractility of prenodal lymph vessels and lymph flow in human leg. Am J Physiol 239(6): H775-783.

Oosthuyse, B., et al. (2001). Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28(2): 131-138.

Orlandini, M., et al. (1996). Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family [published erratum appears in Proc Natl Acad Sci USA 1997 Feb 18;94(4):1603]. Proc Natl Acad Sci USA 93(21): 11675-11680.

Orlandini, M. and S. Oliviero (2001). In fibroblasts Vegf-D expression is induced by cell-cell contact mediated by cadherin-11. J Biol Chem 276(9): 6576-6581.

Paavonen, K., et al. (2000). Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156(5): 1499-1504.

Pain, S. J. and A. D. Purushotham (2000). Lymphoedema following surgery for breast cancer. Br J Surg 87(9): 1128-1141.

Pajusola, K., et al. (1993). Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. Oncogene 8(11): 2931-2937.

Pajusola, K., et al. (1994). Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 9(12): 3545-3555.

Papoutsi, M., et al. (2000). Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem Cell Biol 114(5): 373-385.

Papoutsi, M., et al. (2001). Endogenous origin of the lymphatics in the avian chorioallantoic membrane. Dev Dyn 222(2): 238-251.

Parenti, A., et al. (1998). Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem 273(7): 4220-4226.

Park, J. E., et al. (1994). Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269(41): 25646-25654.

Partanen, T. A., et al. (2000). VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14(13): 2087-2096.

Pepper, M. S., et al. (1991). Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181(2): 902-906.

Petrek, J. A. and M. C. Heelan (1998). Incidence of breast carcinoma-related lymphedema. Cancer 83(12 Suppl American): 2776-2781.

Plate, K. H. (1999). Mechanisms of angiogenesis in the brain. J Neuropathol Exp Neurol 58(4): 313-320.

Plou‘t, J., et al. (1989). Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8(12): 3801-3806.

Poltorak, Z., et al. (1997). VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 272(11): 7151-7158.

Porter, C. J. H. (1997). Drug delivery to the lymphatic system. Crit Rev Ther Drug Carrier Syst 14(4): 333-393.

Potgens, A. J., et al. (1994). Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J Biol Chem 269(52): 32879-32885.

Pressman, J. J., et al. (1967). Lymph node ultrastructure related to direct lymphaticovenous communication. Surg Gynecol Obstet 124(5): 963-973.

Rao, U. R., et al. (1996). Effect of Brugia malayi on the growth and proliferation of endothelial cells in vitro. J Parasitol 82(4): 550-556.

Reynolds, L. P., et al. (1992). Angiogenesis in the female reproductive system. FASEB J 6(3): 886-892.

Richardson, T. P., et al. (2001). Polymeric system for dual growth factor delivery. Nat Biotechnol 19(11): 1029-1034.

Risau, W. (1998). Development and differentiation of endothelium. Kidney Int Suppl 67: S3-6.

Ristimaki, A., et al. (1998). Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273(14): 8413-8418.

Ruohola, J. K., et al. (1999). Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 149(1-2): 29-40.

Sabin, F. R. (1902). On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am J Anat 1: 367-391.

Sabin, F. R. (1909). The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole. Am J Anat 9: 43-91.

Savory, L. J., et al. (2000). Viral vascular endothelial growth factor plays a critical role in orf virus infection. J Virol 74(22): 10699-10706.

Sawano, A., et al. (1996). Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7(2): 213-221.

Scalzetti, E. M., et al. (1991). Developmental lymphatic disorders of the thorax. Radiographics 11(6): 1069-1085.

Schlessinger, J., et al. (2000). Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 6(3): 743-750.

Schmid-Schonbein, G. W. (1990a). Mechanisms causing initial lymphatics to expand and compress to promote lymph flow. Arch Histol Cytol 53 Suppl: 107-114.

Schmid-Schonbein, G. W. (1990b). Microlymphatics and lymph flow. Physiol Rev 70(4): 987-1028.

Schneider, M., et al. (1999). Lymphangioblasts in the avian wing bud. Dev Dyn 216(4-5): 311-319.

Schoppmann, S. F., et al. (2001). Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res 21(4A): 2351-2355.

Seetharam, L., et al. (1995). A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10(1): 135-147.

Senger, D. R., et al. (1997). Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA 94(25): 13612-13617.

Shalaby, F., et al. (1997). A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89(6): 981-990.

Shalaby, F., et al. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376(6535): 62-66.

Shi, Q., et al. (1998). Evidence for circulating bone marrow-derived endothelial cells. Blood 92(2): 362-367.

Shibuya, M., et al. (1990). Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5: 519-524.

Shima, D. T., et al. (1996). The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J Biol Chem 271(7): 3877-3883.

Shweiki, D., et al. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398): 843-845.

Silvester, C. F. (1912). On the presence of permanent communications between the lymphatic and the venous system at the level of the renal veins in adult south american monkeys. Am J Anat 12: 447-471.

Skobe, M., et al. (2001). Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7(2): 192-198.

Soker, S., et al. (1996). Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J Biol Chem 271(10): 5761-5767.

Soldi, R., et al. (1999). Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18(4): 882-892.

Somers, W., et al. (1994). The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372(6505): 478-481.

Stacker, S. A., et al. (2001). VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7(2): 186-191.

Stacker, S. A., et al. (1999a). Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 274(45): 32127-32136.

Stacker, S. A., et al. (1999b). A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability. J Biol Chem 274(49): 34884-34892.

Stainier, D. Y., et al. (1995). Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development 121(10): 3141-3150.

Starling, E. H. (1895-96). On the absorption of fluids from the connective tissue spaces. J Physiol-London 19: 312-326.

Starovasnik, M. A., et al. (1999). Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states. J Mol Biol 293(3): 531-544.

Steffensen, J. F. and J. P. Lomholt (1992). The Secondary Vascular System. Fish Physiology. W. S. Hoar, D. J. Randall and A. P. Farrell. Sab Diego, New York, Boston, London, Sydney, Tokyo, Toronto, Academic Press, Inc. XII, Part A: 185-217.

Stein, I., et al. (1998). Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol 18(6): 3112-3119.

Stone, J., et al. (1995). Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15(7 Pt 1): 4738-4747.

Swartz, M. A. (2001). The physiology of the lymphatic system. Adv Drug Deliv Rev 50(1-2): 3-20.

Taipale, J., et al. (1999). Vascular endothelial growth factor receptor-3. Curr Top Microbiol Immunol 237: 85-96.

Takahashi, T. and M. Shibuya (1997). The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14(17): 2079-2089.

Takahashi, T., et al. (1999). VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18(13): 2221-2230.

Teng, X., et al. (2002). Hypoxia up-regulates mouse vascular endothelial growth factor D promoter activity in rat pulmonary microvascular smooth-muscle cells. Chest 121(3 Suppl): 82S-83S.

Terada, N., et al. (2002). Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416(6880): 542-545.

Tessier, D. C., et al. (1991). Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide. Gene 98(2): 177-183.

Threefoot, S. A. and M. F. Kossover (1966). Lymphaticovenous communications in man. Arch Intern Med 117(2): 213-223.

Tischer, E., et al. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266(18): 11947-11954.

Tomanek, R. J. and R. J. Torry (1994). Growth of the coronary vasculature in hypertrophy: mechanisms and model dependence. Cell Mol Biol Res 40(2): 129-136.

Trutmann, M. and D. Sasse (1994). The lymphatics of the liver. Anat Embryol (Berl) 190(3): 201-209.

Unemori, E. N., et al. (1992). Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153(3): 557-562.

van der Jagt, E. R. (1932). The origin and development of the anterior lymph sacs in the sea turtle (Thalassochelys caretta). Q J Microbiol Sci 75: 151-165.

van der Putte, S. C. (1975a). The development of the lymphatic system in man. Adv Anat Embryol Cell Biol 51(1): 3-60.

van der Putte, S. C. (1975b). The early development of the lymphatic system in mouse embryos. Acta Morphol Neerl Scand 13(4): 245-286.

Vassar, R., et al. (1989). Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci USA 86(5): 1563-1567.

Veikkola, T., et al. (2001). Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20(6): 1223-1231.

Vincent, K. A., et al. (2000). Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation 102(18): 2255-2261.

Vogel, W. O. P. and M. Claviez (1981). Vascular Specialization in Fish, but No Evidence for Lymphatics. Z Naturforsch 36 c: 490-492.

Waltenberger, J., et al. (1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269(43): 26988-26995.

Wang, J. F., et al. (1997). Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor. Blood 90(9): 3507-3515.

Weed, L. H. (1922/1923). The absorption of cerebrospinal fluid into the venous system. Am J Anat 31(3): 191-221.

Weidenreich, F., et al. (1934). Das Lymphgefäßsystem. Handbuch der vergleichenden Anatomie der Wirbeltiere. Bolk, Goppert, Kallius and Lubosch. Berlin and Vienna, Urban und Schwarzenberg: 745-854.

Weller, R. O., et al. (1996). Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol 6(3): 275-288.

Werner, B. (1966). The biochemical composition of the human thoracic duct lymph. Acta Chir Scand 132: 63-76.

Wiesmann, C., et al. (1997). Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91(5): 695-704.

Wigle, J. T., et al. (2002). An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21(7): 1505-1513.

Wigle, J. T. and G. Oliver (1999). Prox1 function is required for the development of the murine lymphatic system. Cell 98(6): 769-778.

Wilting, J. and B. Christ (1996). Embryonic angiogenesis: a review. Naturwissenschaften 83(4): 153-164.

Wilting, J., et al. (1999). Embryonic lymphangiogenesis. Cell Tissue Res 297(1): 1-11.

Wise, L. M., et al. (1999). Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci USA 96(6): 3071-3076.

Witzenbichler, B., et al. (1998). Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 153(2): 381-394.

Wolfel, D. A. (1965). Lymphaticovenous communications; a clinical reality. Am J Roentgenol Radium Ther Nucl Med 95(3): 766-768.

Xia, P., et al. (1996). Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98(9): 2018-2026.

Yamada, Y., et al. (1997). Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 42(3): 483-488.

Zadvinskis, D. P., et al. (1992). Congenital malformations of the cervicothoracic lymphatic system: embryology and pathogenesis. Radiographics 12(6): 1175-1189.

Ziche, M., et al. (1997). Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest 76(4): 517-531.

Zweifach, B. W. and J. W. Prather (1975). Micromanipulation of pressure in terminal lymphatics in the mesentery. Am J Physiol 228(5): 1326-1335.

Previous chapter   | Back to the title page | E-thesis main page